Pet Nutritional Supplement Market

When the long-standing arrangement between the US Food and Drug Administration and the association that writes animal feed ingredient definitions lapsed on 1 October 2024, the route by which a new pet supplement ingredient gained acceptance changed mid-stream. That matters more in this category than in almost any other consumer product, because a pet supplement sits in an awkward space: marketed like a wellness product, regulated like animal food, and bought by an owner acting on behalf of an animal that cannot report whether it worked. Douglas Insights values the pet nutritional supplement market at USD 2.69 billion in 2025 and expects USD 6.22 billion by 2035, compounding at 8.75%. The estimate is built from the bottom up: about 224 million packs sold in 2025 at an average USD 12.00 each, triangulated against pet populations, supplement penetration rates and retailer scan data. Packs grow 6.2% a year while price adds 2.4%, because veterinary-channel and clinically positioned products are displacing commodity chews. This study sits inside Douglas Insights’ consumer goods and retail coverage and follows the published Douglas Insights methodology.

Why do owners buy supplements for animals?

Pet supplement demand rests on three behaviours that have strengthened together. Pets are living longer, so more of them reach the ages where joint stiffness, cognitive decline and digestive sensitivity appear, and an owner watching a dog struggle onto a sofa will act. Veterinary care has become expensive enough that owners look for things they can do between appointments, and a supplement is the most available of those. And the humanisation of pet ownership means the same owner taking a probiotic themselves sees no oddity in buying one for their dog. Douglas Insights counts roughly 224 million packs sold in 2025 against a global pet population in the hundreds of millions, so penetration remains modest even in the most developed markets, which is why the pack leg of this forecast grows 6.2% a year.

What does this market include?

The pet nutritional supplement market covers products given in addition to a complete diet to support a specific aspect of animal health. Joint and mobility products cover glucosamine, chondroitin, green-lipped mussel and similar formulations, usually for ageing dogs. Digestive and probiotic products cover live probiotic cultures, prebiotics and enzyme blends. Skin and coat products cover omega fatty acid formulations, including fish and algal oils. Calming, cognitive and other products cover anxiety formulations, senior cognitive support, urinary and immune products. Value is measured at retail selling price across veterinary, specialty, grocery and online channels. Complete pet foods including those with functional claims, veterinary therapeutic diets, and prescription medicines sit outside the boundary.

What drives pet supplement demand?

Four forces carry the 8.75% revenue path.

The first driver is the ageing pet population. Veterinary practice has extended pet lifespans materially over two decades, and the senior segment is where supplement use concentrates: joint and mobility products alone account for USD 860.1 million of 2025 value, 32% of the market and the largest single category.

The second driver is the shift toward the veterinary channel. A recommendation from a veterinarian converts a discretionary purchase into a considered one, and products sold through clinics command premiums of 40% to 90% over comparable grocery formulations. This channel shift is the main reason the price leg of this forecast runs at 2.4% a year.

The third driver is functional format innovation. Soft chews have largely replaced tablets and powders because administration is the practical constraint in this category: a supplement a dog refuses is a supplement that does not get repurchased, and palatability drives repeat rates more than efficacy claims do.

The fourth driver is regulatory clarification. The lapse of the ingredient definition arrangement in October 2024 and the consultation process that replaced it are prompting manufacturers to document ingredient status more carefully, which raises barriers for the smallest entrants while legitimising the category for larger retailers. Ingredient and labelling requirements are set out in the FDA guidance document library, and trade in the underlying ingredients is recorded by UN Comtrade.

What restrains the pet supplement market?

Three restraints are modelled. Evidence quality is the first and the most fundamental: clinical support for several widely sold ingredients is thin, veterinary opinion is divided, and a category built on owner belief is vulnerable to a well-publicised study that fails to replicate. Functional food substitution is the second: complete diets increasingly carry joint, digestive and skin claims of their own, and an owner whose food already promises those benefits may see no reason to add a supplement. Price sensitivity is the third: this is discretionary spending on a non-human family member, and it compresses in a downturn faster than veterinary care or food does.

Which categories carry the value?

Joint and mobility supplements lead the pet nutritional supplement market with 32% of 2025 value, USD 860.1 million, because the ageing dog population is the clearest and most visible use case an owner can identify without a diagnosis. Digestive and probiotic products are worth USD 698.9 million in 2025, 26% of value, and grow fastest as the microbiome argument that reshaped human supplements, sized in the Nutraceutical Products Market report, crosses into pets. Skin and coat products account for USD 591.4 million, 22% of value, the most established category and the one where owners judge results visually. Calming, cognitive and other products are worth USD 537.6 million, 20% of value, a grouping that includes the fastest-moving new launches, particularly anxiety formulations.

Which category grows fastest?

Digestive and probiotic products grow fastest, at an estimated 11.2% a year against a market average of 8.75%, and the reason is transfer rather than novelty. Owners who adopted probiotics for themselves understand the proposition immediately, which removes the explanation burden that slows most new supplement categories. Veterinary recommendation also runs higher here than in joint products, because digestive upset presents as a specific complaint that brings the animal into the clinic. Calming and cognitive products grow next on new launches, while skin and coat grows slowest as the most mature category.

Who buys, for which animals, and where?

By animal, dogs account for the large majority of pet supplement value, because they are more numerous in supplement-using households, live long enough to develop the conditions these products address, and accept oral administration more readily. Cats form a smaller but faster-growing share, constrained mainly by palatability: a cat that declines a chew ends the purchase. Other companion animals, including horses in some markets, make up the remainder. By channel, veterinary clinics carry the highest value per pack and the strongest repeat rates, pet specialty retail carries the widest assortment, online subscription is the fastest-growing route because supplements suit replenishment, and grocery carries the lowest prices and the least advice. The channel a brand chooses effectively determines its price point, since the same active ingredients sell at very different prices depending on who recommends them.

Where are pet supplements sold?

North America leads the pet nutritional supplement market with 44% of 2025 value, USD 1.18 billion, growing 8.0% a year, on the highest supplement penetration, the strongest veterinary channel and the most developed online subscription market. Europe holds 26%, USD 698.9 million, at 8.4%, where pet ownership is high but supplement penetration lags North America and where marketing claims face tighter scrutiny. Asia Pacific holds 22%, USD 591.4 million, and grows fastest at 10.29%, driven by rapid growth in pet ownership across China, Japan and South Korea, where the category is being adopted by first-generation pet owners with no habit of feeding supplements. Latin America contributes USD 134.4 million at 9.2% on Brazilian and Mexican pet ownership, the Middle East USD 53.8 million at 9.8%, and Africa USD 26.9 million at 9.0% from the smallest base.

Who supplies pet supplements?

The market splits between animal health companies and consumer brands. Zoetis, Elanco and Virbac sell through veterinary clinics, where their existing clinic relationships and regulatory experience matter more than shelf presence. Nestlé Purina and Mars Petcare, through brands including Purina Pro Plan Veterinary Supplements, bring scale and distribution that no specialist can match. Nutramax Laboratories holds an unusually strong position for a specialist, built on clinically studied joint products sold through veterinarians. Vetoquinol, Zesty Paws and NaturVet serve retail and online channels, the last two built largely on chew formats and e-commerce. Douglas Insights estimates the top three suppliers hold roughly 24% of 2025 value, a low concentration for a consumer category, explained by low barriers to launching a chew and by the number of brands competing on packaging and palatability rather than on evidence.

How are pet supplements priced?

Average realised retail price is USD 12.00 per pack in 2025, and the channel spread is wider than the product spread. A grocery-channel joint chew sells at USD 8 to USD 15 for a month’s supply. The same active ingredients in a veterinary-channel product sell at USD 25 to USD 55, and that premium reflects the recommendation, the clinical positioning and the dosing support rather than a proportionate difference in formulation cost. Probiotic products run USD 15 to USD 40 depending on strain count and stability claims. Online subscription pricing typically sits 10% to 20% below equivalent retail, trading margin for retention. Douglas Insights holds price growth at 2.4% a year on channel and positioning shift rather than on inflation in any single format.

Douglas Exclusive: the penetration and repeat-rate model

The penetration and repeat-rate model holds, by country and animal type, what share of pet-owning households buy supplements, how often they repurchase, and how repeat rates differ by format and channel. It is built around the observation that palatability rather than efficacy drives repurchase, so the model tracks format mix alongside penetration. Buyers use it to judge whether a market is under-penetrated or simply has poor retention, which are very different commercial problems.

Scenarios to 2035

The base case pairs 6.2% pack growth with 2.4% price growth for an 8.75% revenue rate and USD 6.22 billion in 2035. An evidence-scrutiny scenario, in which clinical challenges to common ingredients gain traction and functional diets absorb demand, sets the legs at 3.4% and 1.0%, landing the market near USD 4.10 billion. A veterinary-adoption scenario, in which clinics recommend supplements routinely and Asian penetration rises faster, sets them at 8.0% and 3.6%, carrying the market past USD 8.60 billion. Each percentage point of pack growth moves the 2035 figure by roughly USD 590 million. Published estimates cluster between 6% and 13%; the Douglas Insights figure sits mid-range because this study models repeat rates rather than assuming every trial purchase becomes a habit. Adjacent pet spending is covered in the Douglas Insights Pet Food Market and Veterinary Pharmaceuticals Market studies.

Methodology and receipts

The model is built from pet populations by country and species, supplement penetration among pet-owning households, repeat purchase rates by format and channel, and realised retail prices, reconciled against retailer scan data and supplier disclosures. The build covers 32 countries, 4 product categories, 2 principal species and 7 supplier disclosure sets, and ties back to about 224 million packs at an average USD 12.00 in 2025. Complete pet foods including functional diets, veterinary therapeutic diets and prescription medicines are excluded. Every figure in the fact sheet carries its own confidence grade, and the working Excel model ships with the licence.

Sources

1. U.S. Food and Drug Administration FDA guidance documents (animal food ingredients and labelling) (2026)
2. United Nations Statistics Division UN Comtrade: international trade flows in supplement ingredients (2026)